Tirzepatide may reduce CVD Risk in Non-Diabetic Overweight Patients Jacinthlyn Sylvia20 Dec 2023 9:30 PM ISTThe outcomes from the SURMOUNT-1 phase 3 trial found tirzepatide to effectively manage the long-term risk of atherosclerotic cardiovascular disease...
High concordance in high Lp(a) levels among first- and second-degree relatives, finds study Medha Baranwal13 Oct 2023 10:30 AM ISTUSA: Findings from a cross-sectional study suggested over 40% yield of cascade screening of first-degree relatives of people with high lipoprotein(a)...
Evinacumab effective and well tolerated for LDL cholesterol lowering in refractory hypercholesterolemia patients: JAMA Medha Baranwal19 Sept 2023 11:30 AM ISTUSA: A recent study published in JAMA Cardiology has demonstrated the potential utility of evinacumab as an effective and generally well-tolerated...
Elevated Lipoprotein A Levels Linked to Increased Atrial Fibrillation Risk Dr. Kamal Kant Kohli14 Aug 2023 10:30 AM ISTAtrial fibrillation (AF) and atherosclerotic cardiovascular disease (ASCVD) have been the focus of extensive research due to their impact on heart...
Moderate-intensity statins and ezetimibe combo okay for very high-risk ASCVD patients: Analysis of RACING trial Dr. Kamal Kant Kohli8 Aug 2023 11:00 AM ISTKorea: A combination of ezetimibe with a moderate-intensity statin could be considered an effective and feasible therapeutic option for patients at...
LDL Electronegativity- a novel determinant of mortality risk in ASCVD Aditi24 Jun 2023 9:30 AM ISTSimon Kraler et al. and colleagues from the Center for Molecular Cardiology, University of Zurich, have highlighted that Reduced low-density...
High-intensity statins lower mortality risk in patients of chronic liver disease patients with ASCVD Dr. Mahalakshmi Sivashankaran26 April 2023 10:45 AM ISTSouth Korea: According to a recent study published in JAHA: Journal of American Heart Association, high-intensity statin treatment was associated with...
Moderate-intensity statin and ezetimibe aid compliance in elderly atherosclerotic patients: Analysis of RACING Trial Medha Baranwal25 April 2023 9:45 AM ISTKorea: Combination therapy with a moderate-intensity statin plus ezetimibe imparts similar cardiovascular (CV) benefits as standard high-dose statin...
Exercise improve arterial stiffness and benefits in ACVD Aditi19 April 2023 9:15 AM ISTA Systematic review entitled "Comparative effectiveness of different types of exercise in reducing arterial stiffness in children and adolescents: a...
High Lp (a), the key driver for CVD and aortic valve stenosis regardless of CRP levels Medha Baranwal16 March 2023 9:45 AM ISTDenmark: A new study has shown that lowering lipoprotein(a) has potential benefits irrespective of the presence or absence of low-grade systemic...
Lipid-lowering drugs impart cardiovascular benefits across all ethnicities and regions: Study Dr. Kamal Kant Kohli28 Feb 2023 9:30 AM ISTAustralia: Regional and ethnic minority groups derive at least as much cardiovascular benefit as majority groups from lipid-lowering therapies,...
Achieving very low LDL-C tied to lower risk of MI, stroke, and death with no safety concerns: FOURIER-OLE analysis Medha Baranwal16 Feb 2023 10:45 AM ISTUSA: Long-term achievement of lower LDL-C levels, down to <20 mg/dL, is associated with a reduced risk of cardiovascular (CV) outcomes and no...
